Израиль - английский - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose monohydrate (as anhydrous); lactic acid as sodium; magnesium chloride hexahydrate; sodium bicarbonate; sodium chloride - solution for peritoneal dialysis - sodium chloride 5.38 g/l; glucose monohydrate (as anhydrous) 22.7 g/l; calcium chloride dihydrate 0.184 g/l; lactic acid as sodium 1.68 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium bicarbonate 2.10 g/l - sodium chloride - sodium chloride - physioneal is indicated whenever peritoneal dialysis is employed including:acute and chronic renal failure severe water retention severe electrolyte imbalance drug intoxication with dialysable substances when a more adequate therapeutic alternative is not available. bicarbonate/lactate based physioneal peritoneal dialysis solutions with a physiological ph are particularly indicated in patients in whom solutions based on lactate buffer only with a low ph cause abdominal inflow pain or discomfort.

Израиль - английский - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose monohydrate (as anhydrous); lactic acid as sodium; magnesium chloride hexahydrate; sodium bicarbonate; sodium chloride - solution for peritoneal dialysis - sodium chloride 5.38 g/l; magnesium chloride hexahydrate 0.051 g/l; calcium chloride dihydrate 0.184 g/l; sodium bicarbonate 2.10 g/l; glucose monohydrate (as anhydrous) 38.6 g/l; lactic acid as sodium 1.68 g/l - calcium chloride - calcium chloride - physioneal is indicated whenever peritoneal dialysis is employed including:acute and chronic renal failure; severe water retention; severe electrolyte imbalance; drug intoxication with dialysable substances when a more adequate therapeutic alternative is not available. bicarbonate/lactate based physioneal peritoneal dialysis solutions with a physiological ph are particularly indicated in patients in whom solutions based on lactate buffer only with a low ph cause abdominal inflow pain or discomfort.

Израиль - английский - Ministry of Health

fresenius medical care israel p.b., ltd. - calcium chloride dihydrate; calcium chloride dihydrate; glucose monohydrate; glucose monohydrate; magnesium chloride hexahydrate; magnesium chloride hexahydrate; sodium chloride; sodium chloride; sodium hydrogen carbonate; sodium hydrogen carbonate - solution for peritoneal dialysis - sodium chloride 11.57 g/l; calcium chloride dihydrate 0.5145 g/l; magnesium chloride hexahydrate 0.2033 g/l; glucose monohydrate 25.0 g/l; magnesium chloride hexahydrate 0.1017 g/l; calcium chloride dihydrate 0.2573 g/l; sodium hydrogen carbonate 2.940 g/l; sodium chloride 5.786 g/l; sodium hydrogen carbonate 5.880 g/l; glucose monohydrate 50.00 g/l - combinations of electrolytes - combinations of electrolytes - end-stage (decompensated ) chronic renal failure of any origin treated with peritoneal dialysis.17/10/2017 בקשה לשינוי משטר מינון שינוי משטר מינון בהתאם למאושר באירופה

Ирландия - английский - HPRA (Health Products Regulatory Authority)

maco pharma (uk) ltd - glucose monohydrate - solution for infusion - 5 %w/v - electrolytes with carbohydrates

Ирландия - английский - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - glucose monohydrate - solution for infusion - 5.0 anhyd %w/v - carbohydrates

Австралия - английский - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - vilanterol trifenatate, quantity: 40 microgram (equivalent: vilanterol, qty 25 microgram); fluticasone furoate, quantity: 100 microgram - inhalation, powder for - excipient ingredients: magnesium stearate; lactose monohydrate - copd,breo ellipta is indicated for symptomatic treatment of patients with copd with a fev1 <70% predicted normal (post-bronchodilator) in patients with an exacerbation history despite regular bronchodilator therapy.,breo ellipta is not indicated for the initiation of bronchodilator therapy in copd.,asthma,breo ellipta is indicated in the regular treatment of moderate to severe asthma in patients who require a medium to high dose inhaled corticosteroid combined with a long-acting beta-2-agonist.,vilanterol, an active ingredient in breo ellipta, is a long-acting beta-2-agonist (laba). a class effect of all labas can be an increased risk of asthma death (see precautions).

Соединенные Штаты - английский - NLM (National Library of Medicine)

nivagen pharmaceuticals, inc - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 250 mg - symptomatic trichomoniasis. metronidazole tablet, usp is indicated for the treatment of t. vaginalis infection in females and males when the presence of the trichomonad has been confirmed by appropriate laboratory procedures (wet smears and/or cultures). asymptomatic trichomoniasis. metronidazole tablet, usp is indicated in the treatment of asymptomatic t. vaginalis infection in females when the organism is associated with endocervicitis, cervicitis, or cervical erosion. since there is evidence that presence of the trichomonad can interfere with accurate assessment of abnormal cytological smears, additional smears should be performed after eradication of the parasite. treatment of asymptomatic sexual partners. t. vaginalis infection is a venereal disease. therefore, asymptomatic sexual partners of treated patients should be treated simultaneously if the organism has been found to be present, in order to prevent reinfection of the partner. the decision as to whether to treat an asymptomatic male partner

Соединенные Штаты - английский - NLM (National Library of Medicine)

american health packaging - famciclovir (unii: qic03ani02) (penciclovir - unii:359hue8fjc) - famciclovir 500 mg - herpes labialis (cold sores) famciclovir tablets are indicated for the treatment of recurrent herpes labialis. genital herpes recurrent episodes famciclovir tablets are indicated for the treatment of recurrent episodes of genital herpes. the efficacy of famciclovir tablets when initiated more than 6 hours after onset of symptoms or lesions has not been established. suppressive therapy famciclovir tablets are indicated for chronic suppressive therapy of recurrent episodes of genital herpes. the efficacy and safety of famciclovir tablets for the suppression of recurrent genital herpes beyond 1 year have not been established. herpes zoster (shingles) famciclovir tablets are indicated for the treatment of herpes zoster. the efficacy of famciclovir when initiated more than 72 hours after onset of rash has not been established. recurrent orolabial or genital herpes famciclovir tablets are indicated for the treatment of recurrent episodes of orolabial or genital herpes in hiv-infected adu

Соединенные Штаты - английский - NLM (National Library of Medicine)

general injectables and vaccines, inc. - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - epinephrine 1 mg in 1 ml - emergency treatment of allergic reactions (type i), including anaphylaxis, which may result from insect stings or bites, foods, drugs, sera, diagnostic testing substances and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. 1.2 hypotension associated with septic shock adrenalin is indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock. none. 8.1 pregnancy risk summary prolonged experience with epinephrine use in pregnant women over several decades, based on published literature, do not identify a drug associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.  however, there are risks to the mother and fetus associated with epinephrine use during labor or delivery (see clinical considerations ).  in animal reproduction studies, epinephrine administered by the subcutaneous route to pregnant rabbits, mice, and hamsters, during the period of organogenesis, resulted in adverse developmen

Австралия - английский - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - glucose monohydrate, quantity: 15 g/l (equivalent: glucose, qty 13.6 g/l); sodium bicarbonate, quantity: 2.1 g/l; sodium chloride, quantity: 5.38 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; sodium lactate, quantity: 1.68 g/l; calcium chloride dihydrate, quantity: 0.184 g/l - solution, dialysis - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - physioneal 40 is indicated for use in peritoneal dialysis in patients with acute or chronic renal failure.